Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: a systematic review

References

• World Health Organization. The Global Burden of Disease: 2004 Update. Switzerland: World Health Organization, 2008
   Google Scholar
• American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society, 2014
   Google Scholar
• Campbell JD, Ramsey SD. The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics 2009;27:199-209
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. The cost of cancer: Table 1. National costs for cancer care in 2010 in billions of dollars by cancer site. National Cancer Institute, 2011
   Google Scholar
• National Comprehensive Cancer Network. Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology, Version 1. National Comprehensive Cancer Network, 2014
   Google Scholar
• National Cancer Institute. NCI Dictionary of Cancer Terms. Available at: http://www.cancer.gov/dictionary?CdrID=44788 [Last accessed 10 September 2013]
   Google Scholar
• Hondermarck H. Breast cancer: when proteomics challenges biological complexity. Mol Cell Proteomics 2003;2:281-91
   PubMed Web of Science ®Google Scholar
• American Cancer Society. What is Breast Cancer? Available at: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-what-is-breast-cancer [Last accessed 10 September 2013]
   Google Scholar
• Cote ML, Ruterbusch JJ, Alosh B, et al. Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Prev Res (Phila) 2012;5:1375-80
   PubMed Web of Science ®Google Scholar
• Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51
   PubMed Web of Science ®Google Scholar
• Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71:1258-65
   PubMed Web of Science ®Google Scholar
• Papanicolaou GN, Holmquist DG, Bader GM, et al. Exioliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer 1958;11:377-409
   PubMed Web of Science ®Google Scholar
• Fabian CJ, Kimler BF. Breast cancer risk prediction: should nipple aspiration fluid cytology be incorporated into clinical practice? J Natl Cancer Inst 2001;93:1762-3
   PubMed Web of Science ®Google Scholar
• King EB, Barrett D, King MC, et al. Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol 1975;64:728-38
   PubMed Web of Science ®Google Scholar
• Petrakis NL. Nipple aspirate fluid in epidemiologic studies of breast disease. Epidemiol Rev 1993;15:188-95
   PubMed Web of Science ®Google Scholar
• Bentz J. The role of nipple-aspirate fluid cytology in breast-cancer risk screening. MLO Med Lab Obs 2009;41:8,10,12-17
   Google Scholar
• Baltzell KA, Moghadassi M, Rice T, et al. Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: a historic prospective study. BMC Cancer 2008;8:75
   PubMed Web of Science ®Google Scholar
• Buehring GC, Letscher A, McGirr KM, et al. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study. Breast Cancer Res Treat 2006;98:63-70
   PubMed Web of Science ®Google Scholar
• Dooley WC, Ljung BM, Veronesi U, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001;93:1624-32
   PubMed Web of Science ®Google Scholar
• Filassi JR, Zonta MA, Trinconi A, et al. Can breast nipple fluid collected with automated aspiration and preserved in based-liquid solution improve the cytological samples? Acta Cytol 2013;57:276-80
   PubMed Web of Science ®Google Scholar
• Kato I, Ren J, Visscher DW, et al. Nutritional predictors for cellular nipple aspirate fluid: Nutrition and Breast Health Study. Breast Cancer Res Treat 2006;97:33-9
   PubMed Web of Science ®Google Scholar
• King EB, Barrett D, Petrakis NL. Cellular composition of the nipple aspirate specimen of breast fluid. II. Abnormal findings. Am J Clin Pathol 1975;64:739-48
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S, Sneige N, Thompson PA, et al. Nipple aspirate fluid cytology in breast carcinoma. Cancer 2003;99:97-104
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S, Zhao L, Hayes K, et al. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer 2004;102:322-7
   PubMed Web of Science ®Google Scholar
• Proctor KA, Rowe LR, Bentz JS. Cytologic features of nipple aspirate fluid using an automated non-invasive collection device: a prospective observational study. BMC Womens Health 2005;5:10
   PubMedGoogle Scholar
• Sartorius OW, Smith HS, Morris P, et al. Cytologic evaluation of breast fluid in the detection of breast disease. J Natl Cancer Inst 1977;59:1073-80
   PubMed Web of Science ®Google Scholar
• Sauter ER, Ehya H, Babb J, et al. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer 1999;81:1222-7
   PubMed Web of Science ®Google Scholar
• Sauter ER, Ross E, Daly M, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 1997;76:494-501
   PubMed Web of Science ®Google Scholar
• Sauter ER, Wagner-Mann C, Ehya H, et al. Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. Cancer Detect Prev 2007;31:50-8
   PubMedGoogle Scholar
• Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 2001;93:1791-8
   PubMed Web of Science ®Google Scholar
• Zimmerman AL, King EB, Barrett DL, et al. The incidence and significance of intracytoplasmic calcifications in nipple aspirate specimens. Acta Cytol 1977;21:685-92
   PubMed Web of Science ®Google Scholar
• Sauter ER, Ehya H, Mammen A, et al. Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsy. Br J Cancer 2001;85:1952-7
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Conference. The uniform approach to breast fine-needle aspiration biopsy. Am J Surg 1997;174:371-85
   PubMed Web of Science ®Google Scholar
• Papanicolaou GN. Atlas of Exfoliative Cytology. Cambridge, Mass: Howard University Press, 1954
   Google Scholar
• Black MM, Chabon AB. In situ carcinoma of the breast. Path Ann 1969;4:185-210
   Google Scholar
• Petrakis NL. Genetic–environmental interactions in relation to low dose studies: a possible model from breast cancer. Environ Health Perspect 1981;42:97-102
   PubMed Web of Science ®Google Scholar
• Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992;135:130-41
   PubMed Web of Science ®Google Scholar
• Buehring GC. Screening for breast atypias using exfoliative cytology. Cancer 1979;43:1788-99
   PubMed Web of Science ®Google Scholar
• King EB, Chew KL, Hom JD, et al. Multiple sampling for increasing the diagnostic sensitivity of nipple aspirate fluid for atypical cytology. Acta Cytol 2004;48:813-17
   PubMed Web of Science ®Google Scholar
• King EB, Chew KL, Petrakis NL, et al. Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst 1983;71:1115-21
   PubMed Web of Science ®Google Scholar
• Lee MM, Petrakis NL, Wrensch MR, et al. Association of abnormal nipple aspirate cytology and mammographic pattern and density. Cancer Epidemiol Biomarkers Prev 1994;3:33-6
   PubMed Web of Science ®Google Scholar
• Petrakis NL. Cerumen phenotype and epithelial dysplasia in nipple aspirates of breast fluid. Am J Phys Anthropol 1983;62:115-18
   PubMed Web of Science ®Google Scholar
• Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996;5:785-94
   PubMed Web of Science ®Google Scholar
• Petrakis NL, King EB. Cytological abnormalities in nipple aspirates of breast fluid from women with severe constipation. Lancet 1981;2:1203-4
   PubMed Web of Science ®Google Scholar
• Petrakis NL, King EB, Lee M, et al. Cerumen phenotype and proliferative epithelium in breast fluids of U.S.-born vs. immigrant Asian women: a possible genetic–environmental interaction. Breast Cancer Res Treat 1990;16:279-85
   PubMed Web of Science ®Google Scholar
• Wrensch M, Petrakis NL, King EB, et al. Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy. Am J Epidemiol 1993;137:829-33
   PubMed Web of Science ®Google Scholar
• Tice JA, Miike R, Adduci K, et al. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population. Cancer Epidemiol Biomarkers Prev 2005;14:324-8
   PubMed Web of Science ®Google Scholar
• Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698-708
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Medications for risk reduction of primary breast cancer in women. Topic page 2013. Available at: http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrpv.htm [Last accessed 24 September 2013]
   Google Scholar
• Bevers TB, Armstrong DK, Arun B, et al. Breast cancer risk reduction. J Natl Compr Canc Netw 2010;8:1112-46
   PubMed Web of Science ®Google Scholar